CELL BIOTECH CO (049960) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, CELL BIOTECH CO (049960) reported revenue of 53.1 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202553.1 billion KRW7.9 billion KRW10.1 billion KRW[source]
202449.9 billion KRW6.8 billion KRW15.1 billion KRW[source]
202353.8 billion KRW2.2 billion KRW6.3 billion KRW[source]
202250.5 billion KRW6.1 billion KRW8.3 billion KRW[source]
202146.9 billion KRW7.3 billion KRW10.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025134.1 billion KRW4.0 billion KRW130.0 billion KRW[source]
2024128.2 billion KRW5.1 billion KRW123.1 billion KRW[source]
2023116.7 billion KRW4.1 billion KRW112.6 billion KRW[source]
2022116.7 billion KRW5.4 billion KRW111.3 billion KRW[source]
2021112.5 billion KRW5.0 billion KRW107.5 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice